Kevin Williamson - 01 Jan 2026 Form 4 Insider Report for Tenon Medical, Inc. (TNON)

Role: Chief Financial Officer, Director
Signature: /s/ Kevin Williamson
Issuer symbol: TNON
Transactions as of: 01 Jan 2026
Net transactions value: -$17,244
Form type: 4
Filing time: 05 Jan 2026, 20:50:44 UTC
Previous filing: 15 Oct 2025
Next filing: 05 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Williamson Kevin	Chief Financial Officer, Director	104 COOPER COURT, LOS GATOS	/s/ Kevin Williamson	05 Jan 2026	0002037535

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TNON	Common Stock	Options Exercise	$0	+58,987	+2832%	$0.000000	61,070	01 Jan 2026	Direct	F1
transaction	TNON	Common Stock	Tax liability	$17,244	-18,518	-30%	$0.9312	42,552	05 Jan 2026	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TNON	Restricted Stock Units	Options Exercise	$0	-58,987	-50%	$0.000000	58,987	01 Jan 2026	Common Stock	58,987		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents conversion of 58,987 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 58,987 shares of common stock of the Issuer on January 1, 2026.
F2	These shares were sold to pay tax liability associated with the vesting of RSUs.
F3	Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.